# Lexicon Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference
Canonical URL: https://biopharmsignal.com/news/LXRX/lexicon-pharmaceuticals-to-present-at-the-2026-jefferies-global-healthcare-confe-9895b44d
Ticker: LXRX
Company: Lexicon Pharmaceuticals
Source: Lexicon Pharmaceuticals
Published: 2026-05-28 12:30 EST
## Summary

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will...

## Article Body
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on June 4, 2026 at 2:00 p.m. ET in New York City.

The live event and a replay of the presentation can be accessed via the Events page of the Company’s website at https://investors.lexpharma.com/ .

About Lexicon Pharmaceuticals Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Lexicon has a pipeline of drug candidates in discovery, preclinical, and clinical development in neuropathic pain, hypertrophic cardiomyopathy (HCM), obesity and metabolic disorders, and other cardiometabolic indications. For additional information, please visit www.lexpharma.com .

For Media Inquiries: Dave Belian Lexicon Pharmaceuticals, Inc. lexinvest@lexpharma.com For Investor Inquiries: Lisa DeFrancesco Lexicon Pharmaceuticals, Inc. lexinvest@lexpharma.com
## Recent Company News
- 2026-07-27 12:30 EST — [Lexicon Pharmaceuticals Completes Enrollment of Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomatic Non-Obstructive and Obstructive Hypertrophic Cardiomyopathy (HCM)](https://biopharmsignal.com/news/LXRX/lexicon-pharmaceuticals-completes-enrollment-of-pivotal-phase-3-sonata-hcm-study-684930b3) — Source: Lexicon Pharmaceuticals
- 2026-06-03 12:00 EST — [Lexicon to Present Data at the American Diabetes Association (ADA) 2026 Scientific Sessions](https://biopharmsignal.com/news/LXRX/lexicon-to-present-data-at-the-american-diabetes-association-ada-2026-scientific-60360dc3) — Source: Lexicon Pharmaceuticals
- 2026-05-28 12:30 EST — [Lexicon Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference](https://biopharmsignal.com/news/LXRX/lexicon-pharmaceuticals-to-present-at-the-2026-jefferies-global-healthcare-confe-9895b44d) — Source: Lexicon Pharmaceuticals
- 2026-05-12 12:30 EST — [Lexicon Pharmaceuticals to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference](https://biopharmsignal.com/news/LXRX/lexicon-pharmaceuticals-to-present-at-the-4th-annual-h-c-wainwright-bioconnect-i-e7889bc9) — Source: Lexicon Pharmaceuticals
- 2026-05-07 11:30 EST — [Lexicon Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Clinical Updates](https://biopharmsignal.com/news/LXRX/lexicon-pharmaceuticals-reports-first-quarter-2026-financial-results-and-provide-4b7317fd) — Source: Lexicon Pharmaceuticals
## Related News
- 2026-07-28 20:15 EST — BDX — [BD Board Declares Dividend](https://biopharmsignal.com/news/BDX/bd-board-declares-dividend-ea66eb4a)
- 2026-07-28 13:00 EST — ENLV — [Enlivex Announces $400,000,000 Private Placement](https://biopharmsignal.com/news/ENLV/enlivex-announces-400-000-000-private-placement-20e71a7a)
- 2026-07-28 12:30 EST — XRAY — [Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship](https://biopharmsignal.com/news/XRAY/dentsply-sirona-advances-commercial-growth-strategy-in-canada-through-expanded-m-e2440bb2)
- 2026-07-28 12:30 EST — RLMD — [Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer](https://biopharmsignal.com/news/RLMD/relmada-therapeutics-appoints-uro-oncology-leader-bipin-dalmia-as-chief-business-5c4d7b11)
- 2026-07-28 12:05 EST — RIGL — [Rigel Announces Conference Call and Webcast to Report Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/RIGL/rigel-announces-conference-call-and-webcast-to-report-second-quarter-2026-financ-5b987d7a)